Editorial issue 269

The 5 papers selected for this 269th issue of NDT-E were recently published in either NDT (the first 3 ones) or Kidney Int (the last 2 ones).
JJ. Hsu et al. report on the "Association of fibroblast growth factor-23 with arterial stiffness in the Multi-Ethnic Study of Atherosclerosis". In the second paper, M. Ketteler et al focus on "The K-factor in chronic kidney disease: biomarkers of calcification inhibition and beyond". In the third one, F. Locatelli and R. Minutolo focus on the "Intestinal adsorption of uraemic toxins: a new strategy for anaemia management?" Then A.R. Ahmadi et al publish a paper on the "Shifting paradigms in eligibility criteria for live kidney donation: a systematic review". Finally, J.J. Scialla et al report that "An instrumental variable approach finds no associated harm or benefit with early dialysis initiation in the United States".

CME lectures  
The 4 CME lectures of this issue update on recent progress in the field of Lupus nephritis and Rituximab use. Pr Franco Ferrario (Milan, Italy) first present on "The role of repeated biopsies in the management of lupus nephritis". Pr Vladimir Tesar (Prague, Czech Republic) then discusses the place of Rituximab in the treatment of lupus nephritis: do the benefits outweight the risks? Pr Fernando Fervenza (Rochester, USA) details the place of  "Rituximab associated with mycophenolate: the LUNAR trial experience".Finally,  Pr David Jayne (Cambridge, UK) presents an "Update on biologic and stem cell therapies for lupus nephritis".

Enjoy NDT-Edu

Prof. Michel Jadoul
Editor-in-Chief NDT-Educational